Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
about
Tuberculosis Biomarkers: From Diagnosis to ProtectionTh1 and Th17 Cells in Tuberculosis: Protection, Pathology, and BiomarkersNonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCGMycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human TuberculosisQuest for correlates of protection against tuberculosisPrediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathwayRisk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsBeyond macrophages: the diversity of mononuclear cells in tuberculosis.Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot StudySingle Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population.IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune ResponseA Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infectionDiabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovaniNovel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesStimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis.Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection.IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lungImmunological consequences of strain variation within the Mycobacterium tuberculosis complex.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.T cells and adaptive immunity to Mycobacterium tuberculosis in humans.Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.Unintended Immunological Consequences of Biologic Therapy.Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection.Anthelmintic Therapy Modifies the Systemic and Mycobacterial Antigen-Stimulated Cytokine Profile in Helminth-Latent Mycobacterium tuberculosis CoinfectionCytokines and Chemokines in Mycobacterium tuberculosis Infection.Striking the right immunological balance prevents progression of tuberculosis.Yin and yang of interleukin-17 in host immunity to infection.Vaccine research and development: tuberculosis as a global health threat.Protective vaccine efficacy of the complete form of PPE39 protein from Mycobacterium tuberculosis Beijing/K strain in mice.Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections.Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection.
P2860
Q26741141-2409FC7B-D581-4667-A36D-851718F22AB4Q26774207-0D840EFA-A41C-41D7-A810-8FAF9D0B9C10Q26779512-A57649B6-0EB0-4193-8BB5-E4D2CA4276BFQ28083909-1AD73EC3-6D6B-4C46-BCF5-6EBC916A11E8Q28084282-DD4A0265-1F15-46F6-871D-DB3FCB48B573Q30100966-9ED9E21E-F2EF-48C6-B5F9-AEF2F2CA2C84Q30724821-D7648B1C-A461-4F6E-BBE1-084C33519D79Q33809045-C4335656-59DF-4C17-9111-C5E0E2C7E333Q34372502-2DECEAFA-0BD1-4710-A362-5410B8AF4E80Q35609343-3FE8DB2B-AAA9-4690-BD40-D7A5C5DD9188Q35680564-9AE58796-117E-40A1-88E3-94D4157A9FFCQ35913514-27EDA5D3-1397-452F-8117-5F4C9B902E8BQ35922094-23570623-E813-4623-B699-862DBB808E5AQ35945786-A27A6650-D154-47ED-BD30-89CA0DA16C7CQ36338512-C70E518C-2902-494C-B427-15CD46A700DBQ36453623-7ED2B024-778A-49C3-B17E-3235E243B43CQ36555077-1B2D4EC6-D0D0-4893-A9A1-2F8D4A8C346CQ36570892-FC56C6A6-7FC6-49F7-ADBC-0D1A40A94F0DQ36909492-9C4CBF87-3AB8-4CC6-971E-9056145FD7CCQ37284865-8953947F-9CA6-4B9F-87EA-2913D3EBA4A5Q37306934-5410AB89-FC70-4BFC-B8D1-46770D702581Q37393625-74B8AD60-F6A1-4A35-9AB6-A8FDC2A9B587Q37420149-07FE4819-61EE-481A-BF1B-719D968C6419Q37666257-4E196123-B629-4226-A3C6-CB21F5621245Q37717814-6F64C7F5-1957-46AA-83CB-4EA48853CE38Q37737549-E94FA925-F3E9-4B4E-A4F1-C3B43C448E48Q38363792-A69A6243-5936-43F3-B9B9-63D96B226CA1Q38363794-B4473A4C-7218-4BD5-809F-81E6091DE3C2Q38868847-3713CC65-024C-4BA9-BA7F-544D56B47329Q38871098-F0C1E556-4A23-476E-8C2C-2600AE3AA400Q38880052-7DEC23F7-FE20-44BD-984D-FE1C2B89B6CDQ38936163-80AD6AFD-6347-4EF3-B134-ED1B7440A969Q38975396-38378178-4F69-4092-9150-BD5BF3F1415EQ38986062-E2D6A488-09AC-48DB-A749-D0142DC0F384Q39437320-2962B9E3-225D-44B2-81F9-F45B453B9A34Q39438071-F8821E50-D74D-452F-AC25-A2E336E3660AQ40059597-C03C89F6-C97B-4D07-9D94-D7797D7D3C6DQ40064027-78448B1E-7C8D-495F-85BB-C0B4494EB1A9Q40068511-F785AB56-ACE5-4FA3-A661-E480DD8B31DDQ40089069-FF7905B9-9A09-481D-ADCE-B3E47FA31805
P2860
Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@ast
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@en
type
label
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@ast
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@en
prefLabel
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@ast
Unexpected role for IL-17 in p ...... tuberculosis HN878 infection.
@en
P2093
P2860
P1433
P1476
Unexpected role for IL-17 in p ...... m tuberculosis HN878 infection
@en
P2093
Beth A Fallert Junecko
Christina L Stallings
Deepak Kaushal
Emmeline Blanchard
Jay K Kolls
Leticia Monin
Radha Gopal
Samantha Slight
Shabaana A Khader
Todd A Reinhart
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004099
P577
2014-05-15T00:00:00Z